FDA Import Refusal SCS-8459930-9/11/1 — GCS GROUP CO LTD
The FDA refused shipment SCS-8459930-9/11/1 from GCS GROUP CO LTD (South Korea) on Dec 17, 2021. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 2280,333,483,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Dec 17, 2021
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 66VIY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 2280,333,483,75